Interestingly, Ki-67 was significantly elevated in the ‘Eto’ group, which may indicate that a part of the tumor cell population dies as a result of the therapy, while the remaining part continues to grow at a doubled rate (Fig. 2B). The gene discussed is MKI67; the disease is neoplasm.